skip to main content

News and Events

Recent Releases

12/05/2018 - 10:30am

Women with Breast Reconstructions Need Screening Mammography

The University of Michigan research team retrospectively examined 485 women with autologous breast reconstructions (after mastectomies due to breast cancer) who underwent screening mammography over 15 years. The findings suggest that in addition to surveillance, breast cancer patients who undergo mastectomies and autologous tissue reconstruction may benefit from mammography screening of their flaps.
11/27/2018 - 11:30am

Rogel Cancer Center Director Eric Fearon named AAAS fellow

Eric Fearon, M.D., Ph.D., was named a fellow of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers. Fearon is director of the University of Michigan Rogel Cancer Center and Emanuel N. Maisel Professor of Oncology. Several other Rogel Cancer Center members received this honor.
11/26/2018 - 7:30am

Rogel Cancer Center at the American Society of Hematology Annual Conference

Researchers from the University of Michigan Rogel Cancer Center will attend the American Society of Hematology (ASH) Annual Conference Annual Meeting from Saturday, December 1 through Tuesday, December 4. Many of them plan to participate in poster sessions and oral presentations. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
11/15/2018 - 4:15am

New Strategy to Improve Liver Cancer Screening

Liver cancer surveillance among high-risk individuals usually leads to earlier diagnoses and improved survival rates among patients. However, this requires several steps, including identification of high-risk patients, compliance with surveillance recommendations, and highly accurate and accessible imaging tools.
11/01/2018 - 9:00am

Dlugosz to oversee basic science research at Rogel Cancer Center

The University of Michigan Rogel Cancer Center has named Andrzej Dlugosz, M.D., associate director for basic science research. He currently co-leads the Rogel Cancer Center’s cancer biology program. In his new role, Dlugosz will oversee the Rogel Cancer Center’s four basic science research programs.

All Releases